InvestorsHub Logo
Followers 0
Posts 2990
Boards Moderated 0
Alias Born 11/12/2010

Re: jessellivermore post# 18261

Thursday, 07/15/2021 12:07:32 PM

Thursday, July 15, 2021 12:07:32 PM

Post# of 18421
Appreciate your post here, jesse. As a veteran of biotech investing, you probably have leaned a lot--false starts, disappointing clinical trial results, and promising treatments flying under the radar.

The US has the most advanced biotech research because of our ability to raise capital on the public markets for these unproven (as of yet) treatments.

Orphan drugs are not abandoned in the US. They can find a way on to the market with the assistance of the FDA if given the chance to prove their efficacy.

I, too, tend towards biotechs in my higher risk portion of my portfolio. Just like to read the data, trade the swings and hold a core position for he long term if warranted.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News